Mesenchymal Stem Cells

A new article reports an early-phase clinical trial of umbilical cord MSC treatment in COVID‐19 patients

A combination therapy of T regulatory cells and MSCs significantly reduces microgliosis after traumatic brain injury

P-bodies in mesenchymal stem cells support the reprogramming of monocytes and macrophages and the suppression of T-cell responses

FZD5 prevents senescence and preserves multipotency in the most immature, rapidly proliferating MSC subtype

Results of a phase I/IIa study of WJ-MSCs and teriparatide cotreatment for osteoporotic vertebral compression fractures

Extracellular vesicles secreted from MSCs effectively attenuate IVH-associated brain injury in newborn rats

A clinical trial evaluated intra-bone marrow transplantation of third-party MSCs as a means to support cord blood transplantation

Trujillo‐Rodríguez et al. report that MSC infusions do not improve recovery in INRs or reduce immune overactivation or inflammation

Researchers describe an improved one-step injectable approach to the stem cell-mediated repair of cranial bone defects in a mouse model

New findings will aid our understanding of MSC senescence and diseases associated with MSC aging